Vasopressin responses to corticotropin-releasing factor and hypertonicity after truncal vagotomy in dogs.
Infusion of corticotropin-releasing factor (CRF) augments the plasma vasopressin response to infusion of hypertonic saline in conscious dogs. Furthermore, afferent vagal nerve input from the abdomen is involved in the control of vasopressin release and may be altered by CRF. The purpose of the present study was to characterize the effect of CRF on the vasopressin response to hypertonic saline and to determine if it is mediated by afferent input carried from the abdominal vagus. Conscious male dogs (n = 5) underwent infusion of isotonic saline (vehicle), CRF (10 or 20 ng.kg-1.min-1), hypertonic saline (0.2 mmol.kg-1.min-1), or the combination of CRF and hypertonic saline. Hypertonic saline increased plasma sodium from 147 +/- 1 to 153 +/- 1 meq/1 and plasma vasopressin from 2.5 +/- 0.1 to 5.8 +/- 0.4 pg/ml. CRF infusion alone had no effect on plasma vasopressin. The addition of 10 or 20 ng.kg-1.min-1 CRF augmented the vasopressin response to hypertonic saline to 7.7 +/- 1.7 and 6.9 +/- 0.3 pg/ml, respectively. Truncal vagotomy did not attenuate the vasopressin response to hypertonic saline with or without CRF infusion. We conclude that CRF augments the vasopressin response to hypertonic saline and that this effect is not mediated via afferents from the abdominal vagus.
Raff
H
H
Department of Physiology, Medical College of Wisconsin, Milwaukee, USA.
Papanek
P E
PE
Cowles
V E
VE
D000818:Animals; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology*; D004285:Dogs; D004338:Drug Combinations; D008297:Male; D012462:Saline Solution, Hypertonic / Q000494:pharmacology*; D012964:Sodium / Q000097:blood; D015167:Vagotomy, Truncal; D014667:Vasopressins / Q000097:blood*
D004338:Drug Combinations; D012462:Saline Solution, Hypertonic; D014667:Vasopressins; D003346:Corticotropin-Releasing Hormone; D012964:Sodium